Listen to Professor John Rasko AO discussing the results of Cynata's Phase 1 clinical trial of CYP-001 in steroid-resistant acute GvHD, on the Australian Broadcasting Corporation Health Report with Dr Norman Swan and Tegan Taylor.

https://www.abc.net.au/listen/programs/healthreport/3d-printing-heart-transplant/103904548